Imported products are definitely better? Why do some people superstitiously believe in original drugs when generic drugs are of good quality and reasonable price? Recently, the official website of the National Medical Insurance Administration has released relevant content to analyze and provide detailed explanations on issues of general concern to society. Imported products are definitely better? Multinational pharmaceutical companies commission production of formulations globally, and China is the largest exporter of active pharmaceutical ingredients. Many well-known imported pharmaceutical ingredients themselves come from China. From the more than 5 years of national drug procurement practice, it can be seen that high priced imported original research drugs do not necessarily bring high quality, and quality problems may also arise. As of now, among the 9 batches of national organized drug procurement that have been implemented, a total of 1583 domestic generic drugs have been selected, and only 2 products have been reported by the drug regulatory department as having quality risks in quality supervision and inspection, accounting for 0.13%; Out of 70 imported drugs selected, 4 (including 3 original research drugs) were reported as having quality risks by the drug regulatory department during quality supervision and inspection, accounting for 5.71%. The proportion of quality risks in domestic generic drugs is much lower than that of original research drugs. The drug regulatory department has listed all selected products from centralized procurement as a key regulatory focus, and strengthened the full chain quality supervision of production, circulation, and use. Under full coverage supervision and inspection, the annual qualification rate of centrally purchased drugs has reached over 99.8%, higher than the national average level of chemical drugs. Why do some people superstitiously believe in original drugs when generic drugs are of good quality and reasonable price? After arduous research and development and huge investment, enterprises have developed new and good drugs, which are worthy of encouragement and praise, and should receive corresponding returns. Therefore, countries have provided several years of patent protection for innovative drugs, allowing innovative drug enterprises to obtain exclusive returns. But after the patent period, innovative drugs can only be referred to as original research drugs, so it is advisable to consider social benefits more. Other drug production enterprises can imitate them and after strict evaluation and approval, promote them to the market to meet the medication needs of patients. Generic drugs are not inferior drugs, especially those evaluated through quality and efficacy consistency. They are good drugs that are pharmaceutically equivalent and biologically equivalent to the original research drug. Some people think that generic drugs are too cheap to eat, but in fact, the low price is because generic drug companies have identified the path and market, saving a lot of trial and error research and development costs and the process of clinical doctor recognition. In addition, the country has launched centralized quantity based procurement, which is equivalent to wholesale, without intermediaries earning the price difference. Of course, it is much cheaper than retail. The evaluation of the quality and efficacy consistency of generic drugs has been carried out for less than 10 years, and some patients still have a process of understanding and understanding the high-quality development of domestic medicine, while a few have concerns. Because of this, on the basis of quality and efficacy consistency evaluation, the medical insurance department also organized real-world efficacy studies on selected generic drugs in centralized procurement, which showed that the quality and efficacy of the selected generic drugs were consistent with those of the original research drugs and had been publicly released in batches. (Lai Xin She)